Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing

Metastatic breast cancer (MBC) is frequently managed by platinum-based chemotherapy during the disease course. The real benefit of these treatments is uncertain at advanced stages of the disease and in non-triple-negative subtypes. Since homologous recombination deficiency (HRD) could inform about t...

Descripción completa

Detalles Bibliográficos
Autores principales: Galland, Loïck, Ballot, Elise, Mananet, Hugo, Boidot, Romain, Lecuelle, Julie, Albuisson, Juliette, Arnould, Laurent, Desmoulins, Isabelle, Mayeur, Didier, Kaderbhai, Courèche, Ilie, Silvia, Hennequin, Audrey, Bergeron, Anthony, Derangère, Valentin, Ghiringhelli, François, Truntzer, Caroline, Ladoire, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897409/
https://www.ncbi.nlm.nih.gov/pubmed/35246547
http://dx.doi.org/10.1038/s41523-022-00395-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897409/
https://www.ncbi.nlm.nih.gov/pubmed/35246547
http://dx.doi.org/10.1038/s41523-022-00395-0

Ejemplares similares